207 related articles for article (PubMed ID: 10885360)
1. Melanisation of Cryptococcus neoformans in human brain tissue.
Nosanchuk JD; Rosas AL; Lee SC; Casadevall A
Lancet; 2000 Jun; 355(9220):2049-50. PubMed ID: 10885360
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
Rosas AL; Nosanchuk JD; Feldmesser M; Cox GM; McDade HC; Casadevall A
Infect Immun; 2000 May; 68(5):2845-53. PubMed ID: 10768981
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Cryptococcus neoformans: case report and review of the literature.
Patel NC; Ewanowski C; Kupiec-Banasikowska A; Hogan KP
Cutis; 2009 Aug; 84(2):93-6. PubMed ID: 19746767
[TBL] [Abstract][Full Text] [Related]
4. [Melanin and its role on the virulence of Cryptococcus neoformans].
Alp S
Mikrobiyol Bul; 2010 Jul; 44(3):519-26. PubMed ID: 21064003
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
6. A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans.
Banerjee U; Gupta K; Venugopal P
J Med Vet Mycol; 1997; 35(2):139-41. PubMed ID: 9147274
[TBL] [Abstract][Full Text] [Related]
7. Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
Dalisay DS; Saludes JP; Molinski TF
Bioorg Med Chem; 2011 Nov; 19(22):6654-7. PubMed ID: 21715177
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection.
Bryan RA; Jiang Z; Howell RC; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
J Infect Dis; 2010 Aug; 202(4):633-7. PubMed ID: 20594103
[TBL] [Abstract][Full Text] [Related]
9. Hypereosinophilia in disseminated cryptococcal disease.
Marwaha RK; Trehan A; Jayashree K; Vasishta RK
Pediatr Infect Dis J; 1995 Dec; 14(12):1102-3. PubMed ID: 8745027
[No Abstract] [Full Text] [Related]
10. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.
Liu L; Wakamatsu K; Ito S; Williamson PR
Infect Immun; 1999 Jan; 67(1):108-12. PubMed ID: 9864203
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans septicemia in an immunocompetent neonate: first case report in Thailand.
Nakwan N; Ngerncham S; Srisuparp P; Lapphra K; Chokephaibulkit K
Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):697-700. PubMed ID: 19058608
[TBL] [Abstract][Full Text] [Related]
13. Coumaric acid analogues inhibit growth and melanin biosynthesis in Cryptococcus neoformans and potentialize amphotericin B antifungal activity.
Oliveira L; Ferrarini M; Dos Santos AP; Varela MT; CorrĂȘa ITS; Tempone AG; Melhem MSC; Vallim MA; Fernandes JPS; Pascon RC
Eur J Pharm Sci; 2020 Oct; 153():105473. PubMed ID: 32693012
[TBL] [Abstract][Full Text] [Related]
14. Tzanck smear as a rapid diagnostic tool for disseminated cryptococcal infection.
Fridlington E; Colome-Grimmer M; Kelly E; Kelly BC
Arch Dermatol; 2006 Jan; 142(1):25-7. PubMed ID: 16415382
[No Abstract] [Full Text] [Related]
15. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
[No Abstract] [Full Text] [Related]
16. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.
Wang Y; Casadevall A
Antimicrob Agents Chemother; 1996 Mar; 40(3):541-5. PubMed ID: 8851567
[TBL] [Abstract][Full Text] [Related]
17. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcosis and deficiency of interleukin12r.
Rezai MS; Khotael G; Kheirkhah M; Hedayat T; Geramishoar M; Mahjoub F
Pediatr Infect Dis J; 2008 Jul; 27(7):673. PubMed ID: 18520441
[No Abstract] [Full Text] [Related]
19. The discovery of melanin production in Cryptococcus neoformans and its impact on diagnosis and the study of virulence.
Polacheck I
Zentralbl Bakteriol; 1991 Dec; 276(1):120-3. PubMed ID: 1789897
[No Abstract] [Full Text] [Related]
20. Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans.
Chintalacharuvu KR; Matolek ZA; Pacheco B; Carriera EM; Beenhouwer DO
Med Mycol; 2021 Nov; 59(11):1085-1091. PubMed ID: 34332505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]